| Product NDC: | 0338-6011 | 
| Proprietary Name: | Milrinone Lactate in Dextrose | 
| Non Proprietary Name: | MILRINONE LACTATE | 
| Active Ingredient(s): | 200 ug/mL & nbsp; MILRINONE LACTATE | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0338-6011 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075834 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20080602 | 
| Package NDC: | 0338-6011-37 | 
| Package Description: | 200 mL in 1 BAG (0338-6011-37) | 
| NDC Code | 0338-6011-37 | 
| Proprietary Name | Milrinone Lactate in Dextrose | 
| Package Description | 200 mL in 1 BAG (0338-6011-37) | 
| Product NDC | 0338-6011 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | MILRINONE LACTATE | 
| Dosage Form Name | INJECTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20080602 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | MILRINONE LACTATE | 
| Strength Number | 200 | 
| Strength Unit | ug/mL | 
| Pharmaceutical Classes | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |